(Q40545159)

21 September 2017

title

Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target (English)

1 reference

21 September 2017

0 references

8

Young-Joon Surh

1 reference

21 September 2017

9

Yung-Jue Bang

1 reference

21 September 2017

Su-Hyeong Kim

1

1 reference

21 September 2017

Sang-Hyun Song

2

1 reference

21 September 2017

Sang-Gyun Kim

3

1 reference

21 September 2017

Kyung-Soo Chun

4

1 reference

21 September 2017

So-Young Lim

5

1 reference

21 September 2017

Hye-Kyung Na

6

1 reference

21 September 2017

Jae Weon Kim

7

1 reference

21 September 2017

Yong-Sang Song

10

1 reference

21 September 2017

publication date

10 June 2004

1 reference

Journal of Cancer Research and Clinical Oncology

21 September 2017

published in

1 reference

21 September 2017

volume

130

1 reference

21 September 2017

issue

9

1 reference

21 September 2017

page(s)

551-560

1 reference

Aspirin induces cell death and caspase-dependent phosphatidylserine externalization in HT-29 human colon adenocarcinoma cells

21 September 2017

cites work

1 reference

12 December 2020

Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB.

1 reference

12 December 2020

Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression

1 reference

12 December 2020

Celecoxib activates a novel mitochondrial apoptosis signaling pathway

1 reference

12 December 2020

Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac

1 reference

12 December 2020

Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition

1 reference

12 December 2020

Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells

1 reference

12 December 2020

Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.

1 reference

12 December 2020

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

1 reference

12 December 2020

Cyclooxygenases 1 and 2

1 reference

12 December 2020

The influence of prostaglandin antagonists on radiation therapy of carcinoma of the cervix

1 reference

12 December 2020

Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy

1 reference

12 December 2020

15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.

1 reference

12 December 2020

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

1 reference

12 December 2020

Capsaicin suppresses phorbol ester-induced activation of NF-kappaB/Rel and AP-1 transcription factors in mouse epidermis

1 reference

12 December 2020

A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis

1 reference

12 December 2020

Tumor necrosis factor receptor and Fas signaling mechanisms.

1 reference

12 December 2020

High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion

1 reference

12 December 2020

Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer

1 reference

12 December 2020

Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation.

1 reference

12 December 2020

Apoptosis by death factor

1 reference

12 December 2020

Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats

1 reference

12 December 2020

Cyclooxygenase-independent actions of cyclooxygenase inhibitors

1 reference

12 December 2020

Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer

1 reference

12 December 2020

Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines

1 reference

12 December 2020

Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells

1 reference

12 December 2020

Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients.

1 reference

12 December 2020

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

12 December 2020

Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo

1 reference

12 December 2020

Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L

1 reference

12 December 2020

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor

1 reference

12 December 2020

The biochemistry of apoptosis

1 reference

12 December 2020

Colorectal cancer and nonsteroidal anti-inflammatory drugs.

1 reference

12 December 2020

Divinations and surprises: genetic analysis of caspase function in mice

1 reference

12 December 2020

Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors

1 reference

12 December 2020

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

12 December 2020

Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway.

1 reference

12 December 2020

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

12 December 2020

NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action

1 reference

12 December 2020

COX-2 inhibitors for colorectal cancer

1 reference

12 December 2020

Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells

1 reference

12 December 2020

Association between overexpression of cyclooxygenase-2 and suppression of apoptosis in advanced cancer of the uterine cervix after cyclic balloon-occluded arterial infusion.

1 reference

12 December 2020

Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer

1 reference

12 December 2020

Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway

1 reference

12 December 2020

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

1 reference

12 December 2020

Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence

1 reference

12 December 2020

Cyclooxygenase-2 is overexpressed in human cervical cancer.

1 reference

12 December 2020

Aspirin induced apoptosis in gastric cancer cells

1 reference

12 December 2020

Review article: cyclooxygenase--a target for colon cancer prevention

1 reference

12 December 2020

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

1 reference

12 December 2020

Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder

1 reference

12 December 2020

Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells

1 reference

12 December 2020

Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.

1 reference

12 December 2020

A Fas-associated death domain protein-dependent mechanism mediates the apoptotic action of non-steroidal anti-inflammatory drugs in the human leukemic Jurkat cell line

1 reference

12 December 2020

COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells

1 reference

12 December 2020

The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells

1 reference

12 December 2020

Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis

1 reference

12 December 2020

10.1007/S00432-004-0567-6

Identifiers

DOI

1 reference

release_p5i5v6f6sfhixpthjn7tc7e6pa

21 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p5i5v6f6sfhixpthjn7tc7e6pa

24 November 2022

mapped directly with Wikidata item

1 reference